Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

ObjectivesTo evaluate the difference between low-molecular-weight heparin (LMWH) and aspirin in preventing early neurological deterioration (END) and recurrent ischemic stroke (RIS), post-recovery independence, and safety outcomes in acute ischemic stroke.Materials and MethodsWe performed systematic...

Full description

Bibliographic Details
Main Authors: Hui Xia, Ziyao Wang, Min Tian, Zunjing Liu, Zhenhua Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Immunology
Subjects:
ischemic stroke
stroke subtype
large-artery stenosis
low-molecular-weight heparin
aspirin
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.823391/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.823391/full

Similar Items